-+ 0.00%
-+ 0.00%
-+ 0.00%

The share price of Bristol-Myers Squibb rose 3.4% in the premarket as the company continued to recruit patients to participate in Alzheimer's drug trials.

Zhitongcaijing·12/03/2025 13:33:09
Listen to the news
The share price of Bristol-Myers Squibb rose 3.4% in the premarket as the company continued to recruit patients to participate in Alzheimer's drug trials.